Search - tctmd.com

Displaying 361 - 380 of 630

Sort: Relevancy | Date

Presentation TCT 2017

Poland Comments: How Would I Treat This Case?

Presenter: Dariusz Dudek, Martin Hudec, Wojtek Wojakowski

October 30, 2017

Presentation TCT 2017

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Presenter: Dariusz Dudek, Martin Hudec, Marian Branny

October 30, 2017

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

TAVR in Low-Risk Patients

Presenter: Jeroen J. Bax, Axel Linke, Thomas Pilgrim

October 29, 2017

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Caitlin E. Cox

October 06, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Conference News PCR London Valves 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Conference News SCCT 2017

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Yael L. Maxwell

July 08, 2017

News Daily News

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

Alison Palkhivala

July 07, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

Advertisement

Poland Comments: How Would I Treat This Case?

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

TAVR in Low-Risk Patients

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content